Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index; none of the 22 sources its claims cite is checked for support yet.

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach

Open access

Abstract

Introduction: Hydrocortisone is the standard of care in cortisol replacement therapy for congenital adrenal hyperplasia patients. Challenges in mimicking cortisol circadian rhythm and dosing individualization can be overcome by the support of mathematical modelling. Previously, a non-linear mixed-effects (NLME) model was developed based on clinical hydrocortisone pharmacokinetic (PK) pediatric and adult data. Additionally, a physiologically-based pharmacokinetic (PBPK) model was developed for adults and a pediatric model was obtained using maturation functions for relevant processes. In this work, a middle-out approach was applied. The aim was to investigate whether PBPK-derived maturation functions could provide a better description of hydrocortisone PK inter-individual variability when implemented in the NLME framework, with the goal of providing better individual predictions towards precision dosing at the patient level. Methods: Hydrocortisone PK data from 24 adrenal insufficiency pediatric patients and 30 adult healthy volunteers were used for NLME model development, while the PBPK model and maturation functions of clearance and cortisol binding globulin (CBG) were developed based on previous studies published in the literature. Results: Clearance (CL) estimates from both approaches were similar for children older than 1 year (CL/F increasing from around 150 L/h to 500 L/h), while CBG concentrations differed across the whole age range (CBG NLME stable around 0.5 μM vs. steady increase from 0.35 to 0.8 μM for CBG PBPK). PBPK-derived maturation functions were subsequently included in the NLME model. After inclusion of the maturation functions, none, a part of, or all parameters were re-estimated. However, the inclusion of CL and/or CBG maturation functions in the NLME model did not result in improved model performance for the CL maturation function (ΔOFV > −15.36) and the re-estimation of parameters using the CBG maturation function most often led to unstable models or individual CL prediction bias. Discussion: Three explanations for the observed discrepancies could be postulated, i) non-considered maturation of processes such as absorption or first-pass effect, ii) lack of patients between 1 and 12 months, iii) lack of correction of PBPK CL maturation functions derived from urinary concentration ratio data for the renal function relative to adults. These should be investigated in the future to determine how NLME and PBPK methods can work towards deriving insights into pediatric hydrocortisone PK.

Overview

CoChat Summary

TL;DR

This paper tested whether PBPK-derived maturation functions for hydrocortisone clearance and CBG binding could improve an NLME pediatric hydrocortisone PK model in children with CAH. The middle-out implementation did not produce a convincing improvement, and the authors conclude that more balanced clinical data—especially in infants 1–12 months old—are needed.

Key findings

  • In the NLME vs PBPK comparison, hydrocortisone clearance predictions overlapped reasonably well for children and adults older than 1 year, but showed substantial discrepancies in children younger than 1 year.
  • For CBG, the PBPK-derived maturation trend was not represented in the original NLME approach, producing a discrepancy over almost the entire age range.
  • Adding the PBPK-derived CL maturation function to the NLME model did not improve fit: using it as fixed worsened the objective function value by ΔOFV = 34.48, and re-estimating PK parameters while keeping it fixed also worsened fit (ΔOFV = 13.25) and led to convergence problems.
  • Adding the PBPK-derived CBG maturation function improved fit statistics in some runs (ΔOFV = −26.85, −95.51, −53.1, −133.96 depending on estimation step), but often produced unstable or unrealistic parameter estimates, including a very large condition number (1.19 × 10^8) and high IIV in CL (72.5%).

Methods

  • Pediatric data came from an open-label, phase 3, single-center clinical trial in children with adrenal insufficiency, including 23 CAH patients and 1 hypopituitarism patient aged birth to 6 years, with morning oral hydrocortisone granules and plasma cortisol sampling pre-dose, 1 h, and 4 h post-dose, plus extra samples in cohort 1.
  • Adult comparison data came from two crossover studies in healthy males aged 18 to 60 years (Infacort-001, n = 16; Infacort-002, n = 14) with multiple plasma sampling time points after immediate-release hydrocortisone granules.
  • The analysis compared a previously developed NLME model and a previously developed PBPK model, then implemented PBPK-derived maturation functions for 5α-reductase, 11β-HSD2, and CBG into the NLME framework, evaluating performance by GOF plots, NPDEs, OFV, condition number, parameter precision, and empirical Bayes estimates using FOCE+I in NONMEM.

Limitations

  • The paper states that the clinical dataset was sparse, with a notable lack of data between 1 month and 12 months of age, making it difficult to validate the maturation discrepancies in the age range of greatest interest.
  • The PBPK-derived maturation functions themselves are uncertain: the 11β-HSD2 and 5α-reductase functions were derived from urinary metabolite ratios that might need correction for renal function, and the CBG function was fitted on variable data with little data beyond 12 months.
  • Evident from the text: the study did not assess the impact of these model differences on actual dosing recommendations, saying that this was outside the scope of the work.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fphar.2022.1090554

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Comparison of individual apparent hydrocortisone clearance for neonates, infants, children and adults after administration of a pediatric formulation of hydrocortisone. The closed circles represent the individual values taking body weight (non-linear mixed effects model) or body weight and age (maturation function) into account. The lines represent Loess smoothers through the individual values. Age shown on a logarithmic scale.
FIGURE 1 Comparison of individual apparent hydrocortisone clearance for neonates, infants, children and adults after administration of a pediatric formulation of hydrocortisone. The closed circles represent the individual values taking body weight (non-linear mixed effects model) or body weight and age (maturation function) into account. The lines represent Loess smoothers through the individual values. Age shown on a logarithmic scale.CC BY · PubMed Central
FIGURE 2 Comparison of individual hydrocortisone terminal half-life for neonates, infants, children and adults after administration of a pediatric formulation of hydrocortisone. The closed circles represent the individual values taking body weight (non-linear mixed effects model) or body weight and age (maturation function) into account. The lines represent Loess smoothers through the individual values. Age shown on a logarithmic scale.
FIGURE 2 Comparison of individual hydrocortisone terminal half-life for neonates, infants, children and adults after administration of a pediatric formulation of hydrocortisone. The closed circles represent the individual values taking body weight (non-linear mixed effects model) or body weight and age (maturation function) into account. The lines represent Loess smoothers through the individual values. Age shown on a logarithmic scale.CC BY · PubMed Central
FIGURE 3 Comparison of individual cortisol-binding globulin concentrations for neonates, infants, children and adults. The closed circles represent the individual values taking body weight (non-linear mixed effects model) or body weight and age (maturation function) into account. The lines represent Loess smoothers through the individual values. Age shown on a logarithmic scale.
FIGURE 3 Comparison of individual cortisol-binding globulin concentrations for neonates, infants, children and adults. The closed circles represent the individual values taking body weight (non-linear mixed effects model) or body weight and age (maturation function) into account. The lines represent Loess smoothers through the individual values. Age shown on a logarithmic scale.CC BY · PubMed Central
FIGURE 4 Normalized Distribution Prediction Errors (NPDE) of the 4 middle-out models incorporating the PBPK-derived clearance maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived clearance maturation function, run 3: re-estimation of all parameters.
FIGURE 4 Normalized Distribution Prediction Errors (NPDE) of the 4 middle-out models incorporating the PBPK-derived clearance maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived clearance maturation function, run 3: re-estimation of all parameters.CC BY · PubMed Central
FIGURE 5 Individual clearance parameter estimates (empirical Bayes estimate) for the 4 middle-out models incorporating the PBPK-derived clearance maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived clearance maturation function, run 3: re-estimation of all parameters. The dotted line depicts the clearance for a typical individual (i.e. without variability).
FIGURE 5 Individual clearance parameter estimates (empirical Bayes estimate) for the 4 middle-out models incorporating the PBPK-derived clearance maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived clearance maturation function, run 3: re-estimation of all parameters. The dotted line depicts the clearance for a typical individual (i.e. without variability).CC BY · PubMed Central
FIGURE 6 Comparison of individual apparent hydrocortisone clearance for neonates, infants, children and adults after administration of a pediatric formulation of cortisol using the NLME, PBPK or middle-out model (run 2). The closed circles and the lines represent the individual values and Loess smoothers through them. Age shown on a logarithmic scale.
FIGURE 6 Comparison of individual apparent hydrocortisone clearance for neonates, infants, children and adults after administration of a pediatric formulation of cortisol using the NLME, PBPK or middle-out model (run 2). The closed circles and the lines represent the individual values and Loess smoothers through them. Age shown on a logarithmic scale.CC BY · PubMed Central
FIGURE 7 Normalized Distribution Prediction Errors (NPDE) of the 4 middle-out models incorporating the PBPK-derived cortisol-binding globulin (CBG) maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived CBG maturation function, run 3: re-estimation of all parameters.
FIGURE 7 Normalized Distribution Prediction Errors (NPDE) of the 4 middle-out models incorporating the PBPK-derived cortisol-binding globulin (CBG) maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived CBG maturation function, run 3: re-estimation of all parameters.CC BY · PubMed Central
FIGURE 8 Individual clearance parameter estimates (empirical Bayes estimate) for the 4 middle-out models incorporating the PBPK-derived cortisol-binding globulin (CBG) maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived CBG maturation function, run 3: re-estimation of all parameters. The dotted line depicts the clearance for a typical individual (i.e. without variability).
FIGURE 8 Individual clearance parameter estimates (empirical Bayes estimate) for the 4 middle-out models incorporating the PBPK-derived cortisol-binding globulin (CBG) maturation function. Run 0: no re-estimation of parameters, run 1: re-estimation of NLME-derived PK parameters, run 2: re-estimation of NLME-derived PK parameters, run 2: re-estimation of PBPK-derived CBG maturation function, run 3: re-estimation of all parameters. The dotted line depicts the clearance for a typical individual (i.e. without variability).CC BY · PubMed Central
FIGURE 9 Comparison of individual cortisol-binding globulin concentrations for neonates, infants, children and adults using the NLME, PBPK or middle-out model (CBG-run 2 and run 3). The closed circles and the lines represent the individual values and Loess smoothers through them. Age shown on a logarithmic scale.
FIGURE 9 Comparison of individual cortisol-binding globulin concentrations for neonates, infants, children and adults using the NLME, PBPK or middle-out model (CBG-run 2 and run 3). The closed circles and the lines represent the individual values and Loess smoothers through them. Age shown on a logarithmic scale.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 11 Not checked · 31 Own results and interpretations

16 more claims

Create a free account to see all 42 claims and to verify the 22 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 7

Create a free account to see these claims.

Citations

Cites

Show all 41 references

Cited by

See all 5

Metadata

Authors
Michelet, R., Bindellini, D., Melin, J., Neumann, U., Blankenstein, O., Huisinga, W., Johnson, T. N., Whitaker, M. J., Ross, R., & Kloft, C.
Affiliations
  • Freie Universität Berlin (DE)
  • Charité – Universitätsmedizin Berlin (DE)
  • University of Potsdam (DE)
  • Simcyp (United Kingdom) (GB)
  • University of Sheffield (GB)
  • Diurnal (United Kingdom) (GB)
Corresponding author
Michelet, Robin
Venue
Frontiers in Pharmacology
Published
2023-01-12
Volume
13
Pages
1090554-1090554
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4315782250
Cited by
5
References
41
Citations by year
2025: 1 · 2024: 2 · 2023: 2
FWCI
1.02
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion, other-oa)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • publish.UP (University of Potsdam) (submittedVersion, cc-by)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
Funders
Freie Universität Berlin
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords
cortisol, congenital adrenal hyperplasia, cortisol replacement therapy, pediatric pharmacokinetics, middle-out approach, physiologically based pharmacokinetic modeling, nonlinear mixed-effects models, interindividual variability, corticosteroid-binding globulin, precision dosing, adrenal insufficiency, renal function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach. https://app.cochat.ai/papers/10.3389/fphar.2022.1090554
The paper
Michelet, R., Bindellini, D., Melin, J., Neumann, U., Blankenstein, O., Huisinga, W., Johnson, T. N., Whitaker, M. J., Ross, R., & Kloft, C. (2023). Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.1090554

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.